Thrombin-activatable fibrinolysis inhibitor aka procarboxypeptidase U
Bron
Haemostasis and thrombosis: basic principles and clinical practice / Colman [edit.]-p. 381-394
Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma
Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-3:10 (2005) p. 2353-2355
Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease
Bron
Thrombosis and haemostasis : international journal for vascular biology and medicine - ISSN 0340-6245-94:3 (2005) p. 471-487
HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis: a randomized, placebo-controlled study in postmenopausal women
Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-3:5 (2005) p. 1090-1092
Different effects of low-dose transdermal and oral oestrogen therapy on procarboxypeptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study
Bron
Thrombosis and haemostasis : international journal for vascular biology and medicine - ISSN 0340-6245-93:3 (2005) p. 620-622